Scale by Design - Venture Capital Show

S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas

December 20, 2022 SecureVision Season 2 Episode 5
Scale by Design - Venture Capital Show
S2 E5: Why pharma startups need to innovate the drug development process. The importance of a patient first approach w Leen Kawas
Show Notes

Leen Kawas, the Managing General Partner of Propel Bio Partners, shares how her unique background as a pharmacist, entrepreneur, scientist, and investor has influenced her perspective on startups and the drug development lifecycle. 




Our host James Mackey, SecureVision CEO

Listen to our full episode list here:
https://www.scalebydesign.io/

Follow us:
https://www.linkedin.com/company/scalebydesign/

Our YouTube channel:
https://www.youtube.com/@securevision1677

#1 Rated Embedded Recruitment Firm on G2!
https://www.g2.com/products/securevision/reviews

Thanks for listening!